Status:
UNKNOWN
Impact of Number of Rank of B-lactam Antibiotics on Emergence on Multidrug Resistant Bacteria
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Conditions:
Resistant Infection
Antibiotic Resistant Infection
Eligibility:
All Genders
18-100 years
Brief Summary
This study evaluates the impact of rank of Beta lactam antibiotics on emergence of mutlidrug resistant bacteria colonization in intensive care It's retrospective case controle study. Cases are coloni...
Detailed Description
The emergence of multidrug resistant is a wordwide problem. B lactam resistant increase. The antibiotic prescription impact this problem. B lactam antibiotic is prescribed everyday in intensive care ...
Eligibility Criteria
Inclusion
- all patient hospitalized more than 48 hours in intensive care unit in Besançon between january 2016 and december 2017
Exclusion
- patient under guardianship
- patient allergic to Beta lactam
- colonization with mutidrug resistant the first week of hospitalization in intensive care unit
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2019
Estimated Enrollment :
1300 Patients enrolled
Trial Details
Trial ID
NCT03752476
Start Date
January 1 2019
End Date
May 1 2019
Last Update
November 26 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.